Vol 5, No 1 (2009)

Date published: 2009-02-02

Table of Contents

open access

REVIEW ARTICLES

Second-line treatment in non-small cell lung cancer

Maciej Krzakowski

Review paper

Onkol. Prak. Klin 2009;5(1):1-8.

KRAS status as a molecular predictive fac

Aleksandra Łacko, Krzysztof Krzemieniecki

Review paper

Onkol. Prak. Klin 2009;5(1):9-15.
CASE REPORTS
EXPERTS' OPINION

Proposal of defining colorectal cancer subpopulation potentially recommended to bevacizumab treatment. Statement of clinical oncology Advisory Board at Roche Polska Sp. z o.o.

Krzysztof Krzemieniecki, Andrzej Deptała, Kazimierz Drosik, Maria Litwiniuk, Wojciech Rogowski

Guidelines / Expert consensus

Onkol. Prak. Klin 2009;5(1):16-19.
EXPERTS' OPINION

Cutaneous melanoma - diagnostic and therapeutic guidelines

Włodzimierz Ruka, Maciej Krzakowski, Waldemar Placek, Piotr Rutkowski, Zbigniew I. Nowecki, Jacek Fijuth, Anna Nasierowska-Guttmejer, Arkadiusz Jeziorski, Lidia Rudnicka, Paweł Murawa, Janusz Słuszniak, Piotr Potemski, Renata Zaucha, Piotr J. Wysocki, Wojciech Polkowski, Grażyna Kamińska-Winciorek, Stanisław Bajcar, Wojciech Biernat, Edward Towpik

Guidelines / Expert consensus

Onkol. Prak. Klin 2009;5(1):20-32.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl